INOSITOL DERIVATIVES FOR USE IN PATHOLOGICAL CRYSTALLIZATION
The present invention relates to inositol derivatives covalently modified with one, two or three solubility functions, particularly polyethylene glycol moieties, for use in therapy or prevention of conditions related to pathological calcium crystallization, such as cardiovascular calcifications, nep...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | CASTAGNER, BASTIEN IVARSSON, MATTIAS PASCH, ANDREAS LEROUX, JEANRISTOPHE |
| description | The present invention relates to inositol derivatives covalently modified with one, two or three solubility functions, particularly polyethylene glycol moieties, for use in therapy or prevention of conditions related to pathological calcium crystallization, such as cardiovascular calcifications, nephrocalcinosis, calcinosis cutis, chondrocalcinosis and kidney stones.
La présente invention concerne des dérivés d'inositol modifiés de manière covalente avec une, deux ou trois fonctions de solubilité, notamment des fractions de polyéthylène glycol, à utiliser dans le traitement ou la prévention d'états associés à la cristallisation calcique pathologique, telles que les calcifications cardiovasculaires, la néphrocalcinose, la calcinose cutanée, la chondrocalcinose articulaire et les calculs rénaux. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA3005933C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA3005933C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA3005933C3</originalsourceid><addsrcrecordid>eNrjZLDx9PMP9gzx91FwcQ3yDHMM8QxzDVZw8w9SCA12VfD0UwhwDPHw9_F393R29FFwDooMDnH08fGMAir09-NhYE1LzClO5YXS3Azybq4hzh66qQX58anFBYnJqXmpJfHOjsYGBqaWxsbOxoRVAACXNCkc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>INOSITOL DERIVATIVES FOR USE IN PATHOLOGICAL CRYSTALLIZATION</title><source>esp@cenet</source><creator>CASTAGNER, BASTIEN ; IVARSSON, MATTIAS ; PASCH, ANDREAS ; LEROUX, JEANRISTOPHE</creator><creatorcontrib>CASTAGNER, BASTIEN ; IVARSSON, MATTIAS ; PASCH, ANDREAS ; LEROUX, JEANRISTOPHE</creatorcontrib><description>The present invention relates to inositol derivatives covalently modified with one, two or three solubility functions, particularly polyethylene glycol moieties, for use in therapy or prevention of conditions related to pathological calcium crystallization, such as cardiovascular calcifications, nephrocalcinosis, calcinosis cutis, chondrocalcinosis and kidney stones.
La présente invention concerne des dérivés d'inositol modifiés de manière covalente avec une, deux ou trois fonctions de solubilité, notamment des fractions de polyéthylène glycol, à utiliser dans le traitement ou la prévention d'états associés à la cristallisation calcique pathologique, telles que les calcifications cardiovasculaires, la néphrocalcinose, la calcinose cutanée, la chondrocalcinose articulaire et les calculs rénaux.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240528&DB=EPODOC&CC=CA&NR=3005933C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240528&DB=EPODOC&CC=CA&NR=3005933C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CASTAGNER, BASTIEN</creatorcontrib><creatorcontrib>IVARSSON, MATTIAS</creatorcontrib><creatorcontrib>PASCH, ANDREAS</creatorcontrib><creatorcontrib>LEROUX, JEANRISTOPHE</creatorcontrib><title>INOSITOL DERIVATIVES FOR USE IN PATHOLOGICAL CRYSTALLIZATION</title><description>The present invention relates to inositol derivatives covalently modified with one, two or three solubility functions, particularly polyethylene glycol moieties, for use in therapy or prevention of conditions related to pathological calcium crystallization, such as cardiovascular calcifications, nephrocalcinosis, calcinosis cutis, chondrocalcinosis and kidney stones.
La présente invention concerne des dérivés d'inositol modifiés de manière covalente avec une, deux ou trois fonctions de solubilité, notamment des fractions de polyéthylène glycol, à utiliser dans le traitement ou la prévention d'états associés à la cristallisation calcique pathologique, telles que les calcifications cardiovasculaires, la néphrocalcinose, la calcinose cutanée, la chondrocalcinose articulaire et les calculs rénaux.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLDx9PMP9gzx91FwcQ3yDHMM8QxzDVZw8w9SCA12VfD0UwhwDPHw9_F393R29FFwDooMDnH08fGMAir09-NhYE1LzClO5YXS3Azybq4hzh66qQX58anFBYnJqXmpJfHOjsYGBqaWxsbOxoRVAACXNCkc</recordid><startdate>20240528</startdate><enddate>20240528</enddate><creator>CASTAGNER, BASTIEN</creator><creator>IVARSSON, MATTIAS</creator><creator>PASCH, ANDREAS</creator><creator>LEROUX, JEANRISTOPHE</creator><scope>EVB</scope></search><sort><creationdate>20240528</creationdate><title>INOSITOL DERIVATIVES FOR USE IN PATHOLOGICAL CRYSTALLIZATION</title><author>CASTAGNER, BASTIEN ; IVARSSON, MATTIAS ; PASCH, ANDREAS ; LEROUX, JEANRISTOPHE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA3005933C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2024</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CASTAGNER, BASTIEN</creatorcontrib><creatorcontrib>IVARSSON, MATTIAS</creatorcontrib><creatorcontrib>PASCH, ANDREAS</creatorcontrib><creatorcontrib>LEROUX, JEANRISTOPHE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CASTAGNER, BASTIEN</au><au>IVARSSON, MATTIAS</au><au>PASCH, ANDREAS</au><au>LEROUX, JEANRISTOPHE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>INOSITOL DERIVATIVES FOR USE IN PATHOLOGICAL CRYSTALLIZATION</title><date>2024-05-28</date><risdate>2024</risdate><abstract>The present invention relates to inositol derivatives covalently modified with one, two or three solubility functions, particularly polyethylene glycol moieties, for use in therapy or prevention of conditions related to pathological calcium crystallization, such as cardiovascular calcifications, nephrocalcinosis, calcinosis cutis, chondrocalcinosis and kidney stones.
La présente invention concerne des dérivés d'inositol modifiés de manière covalente avec une, deux ou trois fonctions de solubilité, notamment des fractions de polyéthylène glycol, à utiliser dans le traitement ou la prévention d'états associés à la cristallisation calcique pathologique, telles que les calcifications cardiovasculaires, la néphrocalcinose, la calcinose cutanée, la chondrocalcinose articulaire et les calculs rénaux.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA3005933C |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | INOSITOL DERIVATIVES FOR USE IN PATHOLOGICAL CRYSTALLIZATION |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T07%3A33%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CASTAGNER,%20BASTIEN&rft.date=2024-05-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA3005933C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |